Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · VanEck

VanEck Pharmaceutical ETF (PPH)

Ticker PPH · · Holdings as of Jun 30, 2026

Expense ratio
0.36%$36/yr per $10k
5-yr return
+11.3%annualized
1-yr return
+21.9%as of Dec 2025
Net assets
$879.5Mall share classes
Holdings
26

Bottom line

Is PPH a good fund? The bottom line

PPH is a managed health care sector ETF from VanEck.

Annual fees run 0.36% — about $36 a year on every $10,000 invested, cheaper than 90% of health care sector funds we track.

It returned +21.9% over one year, +11.3% a year over five years, +6.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $879 million in net assets and 26 holdings, its largest position is Eli Lilly & Co (20.2%) and the top 10 make up 72.7% of the portfolio.

What stands out

  • Low cost: cheaper than 90% of health care sector peers
  • 5-year return beat 97% of category peers

What to watch

  • Concentrated: top 10 holdings are 72.7% of assets

Updated Nov 19, 2026

What PPH invests in

VanEck Pharmaceutical ETF (the Fund) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (the Pharmaceutical Index or the Index).

The Fund normally invests at least 80% of its total assets in securities that comprise the Funds benchmark index. For purposes of this policy, the term assets means net assets plus the amount of any borrowings for investment purposes. The Pharmaceutical Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. To be initially eligible for the Pharmaceutical Index, companies must generate at least 50% of their revenues from pharmaceuticals. Pharmaceuticals include companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of pharmaceuticals (excluding pharmacies). Of the largest 50 stocks in the pharmaceutical industry by full market…

From the fund's prospectus (filed Jan 27, 2026).

PPH performance

Fund calendar-year total returns, 2016–2025 2016: −17.8%; 2017: +15.4%; 2018: −5.7%; 2019: +19.1%; 2020: +5.2%; 2021: +18.3%; 2022: +2.6%; 2023: +6.9%; 2024: +8.1%; 2025: +21.9% −18% 2016 +15% 2017 −6% 2018 +19% 2019 +5% 2020 +18% 2021 +3% 2022 +7% 2023 +8% 2024 +22% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PPH+21.9%+11.3%+6.7%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full PPH performance history →

What PPH costs

On a $10,000 investment, PPH's 0.36% expense ratio costs about $36 a year. The prospectus estimates $456 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full PPH fee table →

PPH top 10 holdings

#Holding% of fund
1Eli Lilly & Co20.23%
2Novartis AG10.63%
3Merck & Co Inc9.85%
4Novo Nordisk A/S5.37%
5AbbVie Inc4.57%
6Pfizer Inc4.51%
7Bristol-Myers Squibb Co4.47%
8Gsk Plc4.42%
9Johnson & Johnson4.35%
10AstraZeneca PLC4.33%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 72.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to PPH

More funds like PPH →

PPH FAQ

What is the expense ratio of PPH?
PPH's expense ratio is 0.36%, which works out to about $36 a year for every $10,000 invested. The prospectus estimates total costs of $456 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PPH a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 90% of health care sector peers; 5-year return beat 97% of category peers; concentrated: top 10 holdings are 72.7% of assets. This is general information, not personalized advice.
What does PPH hold?
PPH's largest holdings are Eli Lilly & Co (20.2%), Novartis AG (10.6%), Merck & Co Inc (9.8%), Novo Nordisk A/S (5.4%), AbbVie Inc (4.6%). It holds 26 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is PPH's 5-year return?
PPH returned +11.3% a year over the five years ending Dec 31, 2025, and +6.7% a year over ten years. Past performance does not guarantee future results.
Who manages PPH?
PPH is offered by VanEck through VanEck ETF Trust.